The United States Drug Enforcement Administration (DEA) is preparing to pass a rule that would place five tryptamine hallucinogens on Schedule I of the Controlled Substances Act (CSA). These compounds would then be as illegal as heroin, fentanyl or other dangerous drugs. Their possession, use, and manufacture would be a felony that could lead to
Do you want to join us for a webcast about the future of psychedelics? If so, you won’t want to miss the Seminar Group’s upcoming, day-long psychedelics webcast, Legal and Regulatory Landscape for Psychedelics. The webcast will take place virtually on Wednesday, January 26, 2022, starting at 9:00 AM PST. Harris Bricken attorney Griffen Thorne
We’ve been taking early calls on Oregon psilocybin for over a year, going back to when Measure 109 passed. I’m always happy to talk to people, but there simply isn’t much to do yet. Currently, the Oregon Psilocybin Advisory Board (“Board”) and its subcommittees are meeting to formulate recommendations on program rules. Eventually draft rules
Time for another Oregon psilocybin licensing discussion update. We have now crossed the halfway point of the Oregon Health Authority (OHA) two-year development phase to create regulations based on Ballot Measure 109. As a reminder, there are five subcommittees covering different aspects of the emerging psilocybin industry. They include: research, health equity, manufacturing, training, and
This article was first published yesterday on Harvard Law School’s Petrie-Flom Center Bill of Health Blog. On Tuesday, Washington State legislators filed SB 5660, a bill that would legalize the supported adult use of psilocybin by people 21 years of age and older. Sponsored by Senators Jesse Salomon and Liz Lovelett, the bill, known as the Washington Psilocybin
Oregon’s Measure 109 allows for the manufacture, delivery, and administration of psilocybin, the compound found in “magic mushrooms.” But how was psilocybin made illegal in the first place? Originally, psilocybin was illegal under Oregon Revised Statute (ORS) 475.005. This law is Oregon’s “mini” controlled substances act. As in all other states, the Oregon law is
Time for an Oregon psilocybin licensing discussion update. Ballot Measure 109 gave the Oregon Health Authority (“OHA”) two years to create regulations for the manufacturing, testing, sale, and supervised administration of psilocybin. This two-year development phase started on January 1, 2021, and on March 18 Governor Kate Brown appointed members to the Oregon Psilocybin Advisory
Watch the webinar replay below! Psychedelic substances like psilocybin, MDMA, and ketamine are increasingly used in research and clinical medicine. By their very nature, these substances put patients in a vulnerable position. The altered states of consciousness produced by psychedelics can promote insight and healing. However, unscrupulous practitioners can also exploit patients when they are
Psychedelics developments in 2021 covered everything from legalization and decriminalization to pharmaceutical advances and public company milestones.
Harris Bricken is pleased to announce the Psychedelics Law Blog! The Psychedelics Law Blog is a forum for discussing and analyzing the impact of psychedelics laws and reform on industry stakeholders, including health care operators, entrepreneurs, investors, regulators, advocates and others. On this new blog, we will continue to cover the psychedelics law and policy issues
